Olon is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and Generics. We supply more than 300 Active Pharmaceutical Ingredients globally, with one of the most extensive track records in the industry. We provide an integrated package of chemical synthesis and biological processing services which clients can use to manage their drug manufacturing projects fully compliant with regulations. We rely on the broadest technical expertise while maintaining a long-standing quality and reliability Thanks to 2.300 employees and 300 highly experienced and qualified people in R&D team, we are a highly reliable partner. Our global manufacturing networks implies 11 manufacturing sites and 7 R&D departments across the globe, on several decades of experience in supporting pharmaceutical, biotech, food, chemical and bio-industrial companies.
Link esterno per Olon
Pharma's Almanac David Alvaro Thanks for re launching the story!
𝐎𝐥𝐨𝐧 𝐢𝐬 𝐑𝐞𝐚𝐝𝐲 𝐭𝐨 𝐇𝐨𝐬𝐭 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐍𝐞𝐰 𝐅𝐚𝐜𝐢𝐥𝐢𝐭𝐲 𝐃𝐞𝐝𝐢𝐜𝐚𝐭𝐞𝐝 𝐭𝐨 𝐔𝐥𝐭𝐫𝐚-𝐏𝐨𝐭𝐞𝐧𝐭 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝𝐬 Olon, API provider and CDMO global player, confirms the schedule for the construction of its new facility dedicated to ultra-potent compounds in Rodano (Milan), with completion scheduled for January 2025. Learn more here: https://lnkd.in/gi9AbWVq #Olon #CDMO #API #Biomanufacturing #Biopharma
Olon is ready to host productions in the new facility dedicated to ultra potent compounds We have successfully completed the installation and validation of the new Small Scale Production Area within the facility in Rodano (Milan); the installation of the plant for large-scale production will also be completed shortly, with completion scheduled for January 2025. The commercial-scale line will be fully integrated with the small-scale line. The new plant, fully designed to produce payloads, linker payloads, and ultra-potent APIs, is already ready to accommodate small-scale GMP production. In addition to being equipped with the most advanced systems to operate at the highest level of control, it has a dedicated quality control department and storage areas for active ingredients #API #HPAPI #activepharmaceuticalingredients #pharma #pharmasupplychain Read the full story here https://lnkd.in/dV9jpyUu
WE ARE HIRING! We are looking for a REGULATORY AFFAIRS PROFESSIONAL Check out this professional opportunity. In #Olon you can find a dynamic, constantly evolving work environment, open to creativity and personal contribution; an inclusive environment that fosters integration of different cultures and mindsets. Apply here https://lnkd.in/d2hWS78i Explore other opportunities here https://lnkd.in/eCtXQ_3d
Our BD experts will be attending #BioEurope in Stockholm next week! With more than 50 years experience in microbial fermentation, further than mammalian production, bioconjugation, F&F, Olon has developed extensive biotech know how including also High Potent or Toxic Compounds requiring high containment systems. We offer a wide range of expertise from small molecules to large molecules – peptides, enzymes, proteins Meet #Olon at Booth 158
Our partner Antheia, Inc., pharmaceutical ingredient manufacturer transforming essential medicine supply chains, has just announced that it has delivered its first commercial order of #thebaine to a leading pharmaceutical customer. Antheia has continued to produce thebaine at commercial scale with #Olon Andrea Conforto VP CDMO Biotech, comments “We are proud of the contribution we’ve given to this milestone. The partnership between Antheia and Olon is extremely important for the pharmaceutical environment and, overall, for patient’s access to treatments and for the global health. By using Antheia synthetic biology technology and Olon manufacturing asset and experience, we can produce sustainable and quality medicines, not being subject to a fragile and sometimes unpredictable supply chain of #API sourced from nature. As we are doing in the collaboration with Antheia, we can support pharma companies in developing, optimizing and manufacturing for our partners a wide range of molecules” Read the full story here https://lnkd.in/dw2WAP-6
World #ADC Summit will take place next week in San Diego. Come to #Olon booth 214 to meet personally Simona Tommasi, PhD Tim Morgan Fanny Goy Leveraging over four decades of expertise in containment for cytotoxic anticancer production, we stand at the forefront of #ADC payload, payload-linkers and #HPAPI manufacturing with unparalleled safety and efficiency
👨🔬 👩🔬 PEGS EUROPE IS JUST AROUND THE CORNER The Annual Protein & Antibody Engineering Summit is starting November 5th Let's connect in person with Enrico Zanetti and Melusine LARIVIERE and explore the countless opportunities of #Olon #CDMO relying on one the broadest biotech platform to develop and produce API https://lnkd.in/ge4ZTX5
We are pleased to announce the opening of the new state-of-the-art Development Lab-3 in #Olon Mahad (India) site, a cutting-edge facility. The new lab marks a significant milestone in our commitment to driving technological progress and delivering high-quality solutions to our clients and partners. It will not only enhance our internal R&D efforts but also serve as a platform for collaboration with external partners to meet growing demands of the pharmaceutical industry. We are working on the cutting edge of #R&D applied both to #chemistry, with flow chemistry, #photochemistry and #electrochemistry, and to #biotechnologies. High-level expertise and know-how applied to specific processes, consolidated in the 9 research centers, are connected, shared, and extensively applied across the whole of the group’s manufacturing network.
World Vaccine Congress Europe, the largest and most established European meeting on vaccine R&D, is kicking off in one week. #Olon and GTP Bioways, Olon Company, will be exhibiting at Both #74, catch the opportunity to meet personally Nancy MARTINEZ and Amaia Mendivil to explore the one of the most extensive know-how of microbial fermentation applied to CDMO. We are an industry leader in applied biotechnology to industrialization, able to manage the strong complexity implied in the tech transfer and in the scale up of biotech process Meet in Barcelona!